Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Bionure logo — Clinical stage biotech developing new drugs for CNS diseases...

Bionure

Clinical stage biotech developing new drugs for CNS diseases.

Founded 2009 Spain Spain 8 employees Series A Total: $5.07M Biotechnology, Health Care +1

General Information

Company Name Bionure
Founded Year 2009
Location Spain Spain
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Bionure. To contact Bionure, visit bionure.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Bionure

Bionure is a clinical-stage biotech company focused on developing therapies for neurodegenerative diseases that currently lack treatment options. The company's lead candidate, BN201, is a first-in-class small molecule drug that has shown promising results in promoting neuroprotection and remyelination in animal models of damage. This product has received orphan designation for acute optic neuritis in both Europe and the US, and has been licensed to Oculis. Bionure's dedication to patient well-being is evident in their exceptional team of experts in neuro-ophthalmology and neuro-inflammation. Founded in 2009 and headquartered in Spain, Bionure recently secured a €4.00M Series A investment from Alta Life Sciences in May 2018. The company has also outsourced development of part of its portfolio to an investee company while managing the rest internally. Bionure's innovative approach and meaningful impact potential make it a compelling player in the Biotechnology and Health Care industries.

Taxonomy: biotech, neurodegenerative diseases, clinical stage, drug development, neuroprotection, remyelination, orphan designation, ophthalmology, rare diseases, SGK agonists, optic neuritis, neuromyelitis optica, multiple sclerosis, neuro-inflammation, clinical trials

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €4.00M 1
Alta Life Sciences
Alta Life Sciences
17 May 2018
Equity Crowdfunding €1.07M 1
Capital Cell
21 Mar 2017
Series A Undisclosed 1
Hugo Peris
01 Oct 2015

Bionure Alternatives & Competitors

View All Alternatives
Bionure vs
Accure Therapeutics
Accure Therapeutics Spain

R&D pharma dedicated to developing innovative medicines to treat patients suffering from Central ner...

Grant
12 employees
Biotechnology, Health Care
Bionure vs
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics Israel

BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenera...

Post-IPO Equity
36 employees
Biotechnology, Health Care
Bionure vs
Neuraly Inc.
Neuraly Inc. United States

We discover and develop revolutionary treatments for neurodegenerative diseases

Series A
17 employees
Biotechnology, Health Care
View all alternatives

FAQ About Bionure

Clinical stage biotech developing new drugs for CNS diseases.
Bionure was founded in 2009.
Bionure is headquartered in Spain.
Bionure operates in Biotechnology, Health Care and Medical Devices. Its work centres on biotech, neurodegenerative diseases, clinical stage and drug development.
Bionure has approximately 8 employees.
Bionure has completed 3 funding rounds, raising a total of $5.07M. The latest funding stage is Series A.
Top alternatives and competitors to Bionure include Accure Therapeutics, Brainstorm Cell Therapeutics, Neuraly Inc., NeuroGenesis Bio Inc., Rezolute, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bionure and Accure Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bionure, https://bouncewatch.com/company/bionure, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes